AbbVie (ABBV) Seeks Rinvoq Nod for Non-Radiographic AS Posted byZacks Equity Research January 10, 2022 Leave a comment on AbbVie (ABBV) Seeks Rinvoq Nod for Non-Radiographic AS AbbVie’s (ABBV) application seeking approval of Rinvoq for nr-axSpA was based on data from the phase III SELECT-AXIS 2 (Study 2) study.